1、PHARMACEUTICALSUS prescription and institutional sales tracker4 JULY 2025Production time:17:18(London time)See Appendix Disclosure for Analyst Certification,Important Disclosures,Non-USResearch Analyst disclosures and BNP Paribas Group Corporate Social Responsibility(“CSR”)policies.BNP Paribas has a

2、dopted strict CSR policies that govern financing and investment incertainsectors.For timeofdissemination,pleaserefertotheCube.Research Analysts&Publishing EntitiesPeter Verdult,CFABNP Paribas London Branch(+44)203 430 8683Victor FlochBNP Paribas London Branch(+44)203 430 8707Kirsty Ross-StewartBNP P

3、aribas London Branch(+44)203 430 8452Angelin RoyBNP Paribas London Branchbrs015ucsd.edu Brandon Smith 07/09/25 07:35:53 AM University of California San DiegoEMEA Pharmaceuticals teamBNP Paribas Exane|BiographiesVictor FlochAnalyst-EMEA PharmaceuticalsBNP Paribas London Branch(+44)203 430 Victor Floc

4、h joined the BNP Paribas Exane Pharmaceutical team in 2023.Victor previouslyworked at Stifel as well as Bryan,Garnier and Co,as an analyst(Biotechnologies).Victorholds a MSc in Biopharmaceutical Management from ESCP Europe and a Master degreefrom Nantes Pharmacy University.Kirsty Ross-StewartAnalyst

5、-EMEA PharmaceuticalsBNP Paribas London Branch(+44)203 430 8452kirsty.ross-Kirsty joined BNP Paribas Exanes Pharmaceuticals team in London in 2024.Previously,Kirsty spent 2.5 years working for the Citigroups Pharma team and prior to that Kirsty spent 4years in Pharma strategy consulting,focusing on

6、commercial launch strategy and Global drugpricing&market access.Kirsty holds a degree in Medicinal and Biological Chemistry from The University of Edinburghand has passed CFA Levels I and II.Peter Verdult,CFAAnalyst-EMEA PharmaceuticalsBNP Paribas London Branch(+44)203 430 Peter joined BNP Paribas E